Background and objective: To compare the onset of action, and quality of block, of lidocaine 2% with levobupivacaine 0.75% for sub-Tenon's block in patients undergoing cataract surgery. Methods: We performed a two-centre trial in 91 patients who were randomized to receive 4 mL of lidocaine 2% (n ϭ 44) or levobupivacaine 0.75% (n ϭ 47) for sub-Tenon's block, both with hyaluronidase 15 IU mL Ϫ1 . Onset of akinesia was assessed every 2 min for 10 min. Numbers of patients requiring supplementary injections to achieve clinically satisfactory akinesia or rescue analgesia were recorded. Data were analyzed with Fisher's exact test, U-test and t-test where appropriate. Results were considered significant when P Ͻ 0.05. Results: The speed of onset was statistically significantly faster for lidocaine compared to levobupivacaine (3.02 vs. 5.06 min, P Ͻ 0.001). There was no statistical difference in number of patients requiring a supplementary injection of local anaesthetic (levobupivacaine 3 vs. lidocaine 0, P ϭ 0.24), rescue analgesia with topical tetracaine (levobupivacaine 0 vs. lidocaine 2, P ϭ 0.5), or ocular akinesia scores at the completion of surgery (lidocaine 1.4 vs. levobupivacaine 1.6, P ϭ 0.12). Pain scores measured by a verbal analogue scale were not significantly different for injection, perioperatively or postoperatively. Conclusions: Both agents produce a rapid onset of anaesthesia when used for sub-Tenon's block. The difference between the two agents, although statistically significant, is not clinically important.
Introduction
Sub-Tenon's block is increasingly popular for ophthalmic surgery [1] . It is perceived as having advantages over sharp needle techniques in terms of reduced risk of globe perforation, retrobulbar haemorrhage and brainstem anaesthesia. Sub-Tenon's block may be employed for a variety of procedures including rapid cataract extractions or prolonged vitreoretinal procedures. The duration of action may be altered to suit the procedure by manipulation of the local anaesthetic mixture. For cataract extraction lidocaine 2% with hyaluronidase is popular as it has a rapid onset and the duration of action is usually adequate. However, in complicated cases or with a trainee surgeon, its duration of action may be insufficient. Bupivacaine and levobupivacaine have a longer period of action, although they may be avoided in high turnover procedures like cataract extraction, as their onset of action is thought to be prohibitively slow. However, this has never been formally investigated for sub-Tenon's block. Consequently, we performed a two centre, double blind, randomized, controlled trial to assess the onset characteristics and quality of block of lidocaine 2% compared to levobupivacaine 0.75% for sub-Tenon's block.
Method
The study was performed at two centres: The James Cook University Hospital (JCUH), Middlesbrough and St James's University Hospital (SJH), Leeds. The local Ethics Committee at each hospital approved the study. The aim was to recruit 50 ASA I-III patients at each centre. Patients were excluded if they were unwilling to take part, if there were communication or language problems, if there was any history of allergy to amide local anaesthetic agents or preexisting extra-ocular muscle palsy.
Patients were not fasted and did not receive any premedication or sedation. On arrival in the induction room baseline globe movements in the major secondary directions of gaze (superior, inferior, medial and lateral) were assessed. Standard monitoring of pulse oximetry and electrocardiography were commenced and an intravenous (i.v.) cannula was placed. Patients were randomized using a computer generated random order (Excel Microsoft) to receive lidocaine 2% or levobupivacaine 0.75%, both with hyaluronidase 15 IU mL Ϫ1 . Local anaesthetic solutions were prepared by an anaesthetic technician and the individual performing the injection was blinded to which solution they were injecting. Topical anaesthesia of conjunctiva and cornea was achieved by administering 2-3 drops of proxymetacaine 0.5%. The sub-Tenon's block was performed using a 19 G metal cannula in the inferonasal quadrant as described by Stevens [2] . Following test aspiration 4 mL of local anaesthetic solution was injected slowly. Manual compression was performed. Ocular movements were then assessed at 2-min intervals using the scoring system in Table 1 . Full movement (no block) scored 12 points whereas full block scored 0. A score of 4 or less was deemed suitable for surgery. Eyelid movements were scored as present or absent. If after 10 min the block was inadequate for surgery, supplementary anaesthesia was provided by a further injection of up to 3 mL of the test solution by the same technique. Rescue analgesia during surgery was provided with topical tetracaine 1%. At the completion of surgery a further assessment of ocular movement was performed. Immediately after surgery, patients were asked to score pain on injection, during surgery and postoperatively using a verbal analogue scale (VAS) from 0 (no pain) to 10 (worst pain imaginable). Duration of surgery and complications were also noted.
We estimated that onset times would be around 7 and 4 min for levobupivacaine and lidocaine respectively. A power analysis indicated that to detect a difference of 5 min (a ϭ 0.05, b ϭ 0. 
Results
There were no significant differences between the groups in terms of patient characteristics, time to or duration of surgery (Tables 2 and 3 ). The onset time to an akinesia score of 4 are shown in Table 3 . At the point when extra-ocular muscle movement scored 4 or less, eyelid opening was still present in 28 (64%) of the lidocaine and 39 (83%) of the levobupivacaine patients (P ϭ 0.056). At the same point, eye closure was still possible in 16 (36%) of the lidocaine and 22 (47%) of the levobupivacaine patients (P ϭ 0.4). Eyelid movement was not a problem for the surgeon. Generally, both local anaesthetic agents provided good conditions for the patients with no significant difference in pain scores (Table 4 ). However, there was a non-significant trend towards increased perioperative pain in the lidocaine group. A small conjunctival haemorrhage occurred in 26% of lidocaine and 36% of levobupivacaine patients (P ϭ 0.26). Chemosis occurred in 21% of lidocaine and 18% levobupivacaine patients (P ϭ 0.79).
The study was halted prematurely at the James Cook University Hospital following an out-of-study adverse event (a patient undergoing vitreoretinal surgery under peribulbar block administered by an anaesthetist not connected to the study) developed numbness persisting for more than 12 h. No further information is available about this adverse event. Consequently, 41 instead of 50 patients were recruited at The James Cook University Hospital. Results up to this point were used for analysis. 
Discussion
Our results showed that for sub-Tenon's block, lidocaine 2% produced a statistically faster onset than 0.75% levobupivacaine (3.02 vs. 5.06 min). However, even with short procedures a difference of 2 min is unlikely to be clinically relevant. The quality of the block was assessed in terms of perioperative pain scores, numbers requiring rescue analgesia and akinesia at the end of the procedure. The mean perioperative pain scores were low in both groups, although there was a trend towards slightly higher pain scores in the lidocaine group (0.13 vs. 0.53, P ϭ 0.07). However, as only two of the 44 patients in the lidocaine group required rescue analgesia (duration of surgery 14 and 40 min) the quality of block is probably similar and adequate for the vast majority. The duration of action was sufficient in virtually all, with no differences between the two groups as measured by akinesia scores at the completion of surgery. Using the outcome measures that we assessed, there appeared to be no pharmacodynamic differences between the two agents for this procedure. Had we included longer procedures, such as vitrectomy, then the shorter duration of lidocaine is likely to have been revealed. For peribulbar anaesthesia 0.75% levobupivacaine and racemic bupivacaine result in a high incidence of diplopia the day following surgery (42-50%), indicating a prolonged duration of action [3] . We would anticipate a similarly long duration of action for sub-Tenon's anaesthesia with levobupivacaine.
Differences in safety may also determine the choice of local anaesthetic agent. Racemic bupivacaine has been implicated in problematic local anaesthetic toxicity [4] . Levobupivacaine has a similar efficacy to racemic bupivacaine, but reduced cardiovascular and central nervous system toxicity [5] . Despite the wider safety margin of levobupivacaine, systemic toxicity has been reported following brachial plexus blockade using doses of 125 mg and 150 mg [6, 7] . This dose is far in excess of the amount administered by a single injection (30 mg) in this study. However, some authors claim that sub-Tenon's block may be improved with volumes of up to 11 mL (82.5 mg of levobupivacaine 0.75%) [8] . The added safety margin of levobupivacaine over racemic bupivacaine may be relevant for some patients following a rapid intra-vascular injection of this volume. In contrast, lidocaine is the least toxic of the commonly used local anaesthetic agents for ophthalmic regional anaesthesia. The wide therapeutic index affords a greater margin of safety such that i.v. lidocaine is used in volunteer studies to familiarize subjects with premonitory symptoms of local anaesthetic toxicity [9] . The dose administered in this study (80 mg) would be very unlikely to cause problems even in intra-vascular injection.
Local anaesthetic myotoxicity is increasingly recognized as a potential complication of orbital injections. There is no data yet to compare lidocaine with levobupivacaine. However, it is likely that both agents may cause significant damage if injected directly into a muscle. This may occur even in sub-Tenon's anaesthesia as local anaesthetic passes through fenestrations in Tenon's fascia around the muscle insertions [10] . Neurotoxicity is an additional concern for orbital injections. The mechanism may involve primary intra-neural injection, or secondary neuronal ischaemia caused by arterial damage, with or without a mass effect due to retrobulbar haemorrhage. All of the commonly used local anaesthetic agents have been associated with cases of nerve damage following orbital injections [11, 12] . Factors thought to be important include injection into vital structures (optic nerve, ophthalmic artery or globe), particularly in patients with high-risk ocular circulations (diabetes, hypertension or glaucoma). Risks are increased by sharp needle techniques where there Table 4 . Pain scores. is the potential for direct trauma, and where intraocular pressure is known to increase transiently following injection. Although details of the case of prolonged numbness are not known a normal pharmacological effect of this duration seems unlikely, so the mechanism of the prolonged block that prompted the premature completion of the study at The James Cook University Hospital remains unclear. In summary, both lidocaine and levobupivacaine provided a rapid onset of dense sub-Tenon's block. The duration of action was adequate with both agents, even for prolonged cataract extractions. Lidocaine is far cheaper and may be seen as a useful agent for the competent, rapid surgeon performing high turnover list, with levobupivacaine reserved for longer procedures and surgical staff learning new techniques.
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